Interferon: Current and Future Clinical Uses in Infectious Disease Practice

Beasley RP , Lin C-C, Hwang L-Y, Chien C-S. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981; ii: 1129–33

Greenberg HB Pollard RB Lutwick U . Effect of human leucocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 1976; 295: 517–22

Carman WF Jacyna MR Hadziyannis S . Mutation preventing formation of hepatitis B e antigen in chronic HBV infection. Lancet 1989; ii: 588–91

Brook MG Chan G Yap I . Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989; 299: 652–6

Brook MG McDonald JA Karayiannis P . Randomised controlled trial of interferon alfa 2a (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection. Gut 1989; 30: 1116–22

Dusheiko GM Kassianides C Song E . Loss of hepatitis B surface antigen in three controlled trials of alfa recombinant interferon for treatment of chronic hepatitis B. In: Zuckerman AJ , ed. Viral hepatitis and liver disease. New York: Alan R Liss, 1988:844–7

Brook MG Petrovic L McDonald JA . Histological improvement after antiviral treatment for chronic hepatitis B virus infection. J Hepatol 1989; 8: 218–25

Kassianides C Di Bisceglie AM Hoofnagle JH . Alpha-interferon therapy in patients with decompensated chronic type B hepatitis. In: Zuckerman AJ , ed. Viral hepatitis and liver disease. New York: Alan R Liss, 1988:840–3

Perrillo RP Regenstein FG Peters MG . Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis: A randomised controlled trial. Ann Intern Med 1988; 109: 95–199

Perrillo RP Schiff ER Davis GL . A randomised controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment for chronic hepatitis B. N Engl J Med 1990; 323: 295–301

Fattovich G Boscara S Noventa F . Influence of hepatitis delta virus on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987; 155: 931–5

Thomas HC Lever AML Scully LJ . Approaches to the treatment of hepatitis B virus and delta-related liver disease. Semin Liver Dis 1986; 6: 34–41

Alter HJ Purcell RH Shih JW . Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500

Koretz RL Stone O Mousa M Gitnick GL . Non-A, non-B post-transfusion hepatitis—a decade later. Gastroenterology 1985; 88: 1251–4

Tedder RS Gilson RJC Briggs M . Hepatitis C virus: Evidence for sexual transmission. BMJ 1991; 302: 1299–302

Davis GL Balart AL Schiff ER . Treatment of chronic hepatitis C with recombinant interferon alfa: A multi-center randomised, controlled trial. N Engl J Med 1989; 321: 1501–6

Di Bisceglie AM Martin P Kassianides C . Recombinant interferon alfa therapy for chronic hepatitis C: A randomised, double-blind, placebo controlled trial. N Engl J Med 1989; 321: 1506–10

Ho DD Hartshorn KL Rota TR . Recombinant interferon alpha-A suppresses HTLV-III replication in vitro. Lancet 1985; i: 602–4

Krown SE Real FX Cunningham-Rundles S . Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983; 308: 1071–6

DeStefano ERM Friedman AE Friedman-Kein JJ . Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis 1982; 146: 451–5

Joller-Jemelka HI Joller PW . Antibodies to endogenous interferon alpha in controls and HIV infected persons in difference disease states. Abstract ThBP 133; Vth International Conference on Aids, Montreal, 1989

Lau AS Livesey JF . Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon in acquired immunodeficiency syndrome. J Clin Invest 1989; 84: 738–43

Lane HC Davey V Kovacs JA . Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. Ann Intern Med 1990; 112: 805–11

Abrams DI Volberding PA . Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. Semin Oncol 1987:14:43–7

Lane HC Kovacs JA Feinberg J . Anti-retroviral effects of interferon alpha in AIDS-associated Kaposi's sarcoma. Lancet 1988; ii: 1218–22

Sulis E Floris C Sulis ML , Interferon administered intralesionally in skin, conjunctiva and oral cavity lesions in patients with AIDS-related Kaposi's sarcoma. Abstract TBP 292. Vth International Conference on AIDS, Montreal, 1989

Krown SE Gold JWM Niedzwiecki D . Interferon alpha with zidovudine: Safety, tolerance and clinical and virological effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990; 112: 812–21

Ellis M Neal KR Leen CLS Newland AC . Alpha 2-a recombinant interferon in HIV associated thrombocytopenia. BMJ 1987:295:1519

Murray HW Rubin BY Masur H Roberts RB . Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 883–9

Badaro R Falcoff E Badaro FS . Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 1990; 322: 16–21

Yliskoski M Cantell K Syrjanen K Syrjanen S. Topical treatment with human leucocyte interferon of HPV 16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol 1990; 36: 353–7

Frost L Skajaa K Hvidman LE . No effect of intralesional injection of interferon on moderate cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1990; 97: 626–30

Dunham AM McCartney JC McCance DJ Taylor RW . Effect of perilesional injection of alpha interferon on cervical intraepithelial neoplasia and associated human papilloma virus infection. J R Soc Med 1990; 83: 490–2

De Palo G Stefanon B Rilke F Pilott S Ghione M. Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with papilloma virus infection. Int I Tissue Reac 1984; 6: 523–7

Puligheddu P Marcello C Medda F Parodo G Setzu A Lecla U. Activity of interferon beta in condylomata with dysplastic lesion of the uterine cervix. Eur J Gynaecol Oncol 1988; 9: 161–2

Iwasaka T Hayashi Y Yokoyama M . Interferon gamma treatment for cervical intraepithelial neoplasia. Gynecol Oncol 1990; 37: 96–102

Spirtos NM Smith LH Teng NNH . Prospective randomised trial of topical alpha interferon for the treatment of vulvar intraepithelial neoplasia 3. Gynecol Oncol 1990; 37: 34–8

Vesterinen E Meyer B Cantell K . Topical treatment of flat vaginal condyloma with human leucocyte interferon. Obstet Gynecol 1984; 64: 535

Zwiorek L Schmidt-Rhode P Schultz KD . Interferon in the treatment of condylomata acuminata. Geburtshilfe Frauenheilkd 1989; 49: 1001–5

Ikic D Bosnic N Smerdal S. A double blind clinical study with human leucocyte interferon in the therapy of condylomata acuminata. In: Proceedings of a symposium on clinical use of interferon. Yugoslav Academy of Science and Arts, Zagreb 1975:239

Tyring SK . Treatment of condyloma acuminata with interferon. Semin Oncol 1988; 15 (suppl 5): 35–40

Vance J Corwin Bart BJ Hansen RC . Intralesional recombinant alpha 2 interferon for the treatment of patients with condylomata or verruca plantaris. Arch Dermatol 1986; 122: 272–7

Welander CE Homesley HD Smiles KA Peets EA . Intralesional interferon alpha 2b for the treatment of genital warts. Am J Obstet Gynecol 1990; 162: 348–54

Eron LJ Judson F Tucker S . Interferon therapy for condylomata acuminata. N Engl J Med 1986; 315: 1059–64

Workshop Clinicians . Intron A in the treatment of condylomata acuminatum. In: conference proceedings. Interferon and Condyloma Acuminatum. R S Med, London 1988

Maw RD Dinsmore WW Paavonen J , A European mulricentre open study of treatment of condylomata acuminata using podophyllin 25% versus alpha 2 interferon subcutaneously. In: conference proceedings. International Congress on Sexually Transmitted Diseases: Viral Infections as a Cause of Sexually Transmitted Disease. Amsterdam. 1989.

Pannici P Benedetti Scambia G Baochhi G Perrone L Pintus C Mancusco S. Randomised clinical trial comparing systemic interferon with diathermocoagulation in primary multiple and widespread anogenital condyloma. Obstet Gynecol 1989; 74: 393–7

Reichman RC Oakes D Bonnez W . Treatment of condyloma acuminatum with three different interferon alpha preparations administered parenterally: A double blind placebo controlled trial. J Infect Dis 1990; 162: 1270–6

Schonfield A Schattner A Orespi M . Intramuscular human interferon beta injections in treatment of condylomata acuminata. Lancet 1984; 1: 1038–42

Fierlbeck G Schiebel U Muller C. Immunohistology of genital warts in different stages of regression after therapy with interferon gamma. Dermatologica 198; 179: 191–5

Schneider A Papendick U Gissmann L De Villiers EM . Interferon treatment of human genital papilloma virus infection; importance of viral type. Int J Cancer 1987; 40: 610–4

Keay S Teng N Eisenberg N Story B Sellers PW Merigan TC . Topical interferon for treating condylomata acuminata in women. J Infect Dis 1988; 158: 934–9

Boot JM Blog FB Stolz E. Intralesional interferon alpha 2b treatment of condylomata acuminata previously resistant to podophyllin resin application. Genitourin Med 1989; 65: 50–3

Reichman RC Oakes D Bonnez W . Treatment of condylomata acuminatum with three different interferons administered intralesionally. Ann Intern Med 1988; 108: 675–9

Hatch K Bart B Hansen R Millikan L Reichman R Berman B. Evaluation of interferon alpha 2 in the treatment of condyloma acuminata. In: conference proceedings of the 14th International Congress of Chemotherapy, Kyoto, Japan 1985

Friedman-Kien AE Eron LJ Conant M . Natural interferon alpha for treatment of condylomata acuminata. JAMA 1988; 259: 533–8

Geffen JR Klein RJ Friedma-Kien AE . Intralesional administration of large doses of human leucocyte interferon for the treatment of condylomata acuminata. J Infect Dis 1984; 150: 612–5

Gross G Ikenberg H Roussaki A Drees N Schopf E. Systemic treatment of condylomata acuminata with recombinant interferon alpha 2a: Low dose superior to high dose regime. Chemotherapy 1986; 32: 537–41

Gross G Roussaki A Schopf E . Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low dose recombinant interferon alpha. Arch Dermatol 1986; 122: 749–50

Olsen EA Kelly FF Vollmer RT Buddin DA Weck PC . Comparative study of systemic interferon alpha N1 and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 1989; 20: 1023–30

Paavonen J. Subcutaneous interferon alpha in the treatment of refractory condylomata. Sex Transm Dis 1990; 17: 152–3

Gall SA Hughes CE Trofatter K. Interferon for the therapy of condyloma acuminatum. Am J Obstet Gynecol 1985; 153: 157–63

Reichman RC Micha JP Weck PC . Interferon alpha nl for refractory genital warts: Efficacy and tolerance of low dose systemic therapy. Antiviral Res 1988; 10: 41–57

Weck PC Buddin DA Whisnant JK . Interferons in the treatment of genital HPV infections. Am J Med 1988; 85 (suppl 2a): 159–64

Olsen EA Trofatter KF Gall SA . Human lymphoblastoid alpha interferon in the treatment of refractory condylomata. J Invest Dermatol 1985:359–64

Kirby PK Kiviat N Beckman A Wells D Sherwin S Corey L. Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts. Am J Med 1988; 85: 183–8

Piccoli R Santoro MG Nappi C . Vulvovaginal condylomatosis and relapse: Combined treatment with electrocauterisation and beta interferon. Clin Exp Obstet Gynecol 1989; 16: 30–5

Douglas JM Eron LJ Judson FN . A randomised trial of combination therapy with intralesional interferon alpha 2b and podophyllin versus podophyllin alone for the therapy of anogenital warts. J Infect Dis 1990; 162: 52–9

Handley J Maw R Dinsmore W . Subcutaneous interferon alpha 2a combined with cryotherapy versus cryotherapy alone in the treatment of primary anogenital warts: A randomised observer blind placebo controlled study. Genitourin Med 1991 (in press)

Vance J Corwin Davis D. Interferon alpha 2b injections used as an adjuvant therapy to carbon dioxide laser vaporisation of recalcitrant anogenital condylomata acuminata. J Invest Dermatol 1990;(suppl 6):146–8S